Phase i Studies and Their Expansion in India
No one could think that India would emerge as the leading hub for medical tourism in the past few years. With the
improved medical courses, investments in state-of-the-art architecture as well as advanced medical researches,
India today is equipped to diagnose and treat any chronic ailment back to normalcy.
The Southern part of India, especially places like Bangalore, Chennai and Vellore has progressed manifold in terms
of medical colleges, institutions and Clinical Research Organizations. The source of all medical treatment is
research and studies. Eminent CRO's in India today support numerous scientific studies that provide effective
diagnosis. The prominent name today in the medical realm being the Phase i Studies.
Phase I Studies in India
Phase I studies have become increasingly well known in the Indian subcontinent. CRO's in the southern part of the
country and located otherwise, have innovative bioanalytical infrastructure to aid these studies. This apart, there
are student volunteers or volunteers doctors who also contribute in the process. Essential elements of the study
include the following:-
Multiple Ascending Dose studies
Dose Escalating studies
New Chemical Entities
Single Ascending Dose studies
Renowned CRO's in India provides specialized services for First-in-Man studies for a comprehensive range of
biological and chemical entities. This apart other services provided are listed below-
Proof of Mechanism & Proof of Concept
Food Effect, Pharmacokinetic
Drug Interaction studies
Furthermore, there are other diverse studies done for multiple biomarkers and specialized population studies.
Essential aspects in Phase I Studies
The most important aspect in the completion of Phase I Studies is infrastructure. There is also a team of able
professionals helping candidates in this field. Other essential aspects include innovative medical equipments,
experienced nurses and trained physicians.
Mulling on the state of medical researches and Phase i Studies in India depending on a sizeable amount that a full
series trial may need, generally the expense payment responsibility is taken on by an external sponsor. These
sponsors are generally in the form of a pharmaceutical company, biotechnology, or a governmental organization.
Click here for more on biometrics & regulatory services